Sign Up to like & get
recommendations!
0
Published in 2019 at "Future oncology"
DOI: 10.2217/fon-2019-0599
Abstract: Systemic treatments for advanced soft tissue sarcoma are limited. Eribulin showed activity in metastatic soft tissue sarcoma, particularly liposarcomas. Data from six patients with advanced liposarcoma that received eribulin as third- or fourth-line therapy are…
read more here.
Keywords:
experience eribulin;
case;
patients advanced;
eribulin ... See more keywords